Bioject Medical Technologies Inc. Annual Shareholder Meeting Thursday, June 9, 2011

PORTLAND, Ore.--()--Bioject Medical Technologies Inc., (OTCBB: BJCT), a leading developer of needle-free injection therapy systems, announced today that the Company will hold its Annual Shareholder Meeting on Thursday, June 9, 2011 at 9:00 a.m. Pacific Daylight Time at its corporate office in Tualatin, Oregon.

Live audio of the Annual Meeting will be available to investors, members of the news media and the general public. To access the call, please dial 1-877-407-8037. A replay will also be available until June 16, 2011. To listen to the replay, please dial 1-877-660-6853, replay account number 7303, identification number 373862.

Bioject Medical Technologies Inc., based in Portland, Oregon, USA, is an innovative developer and manufacturer of needle-free injection therapy systems (NFITS). NFITS provide an empowering technology and work by forcing medication at high speed through a tiny orifice held against the skin. This creates a fine stream of high-pressure fluid penetrating the skin and depositing medication in the tissue beneath. Bioject is focused on developing mutually beneficial agreements with leading pharmaceutical, biotechnology, and veterinary companies, as well as research, global health and government organizations.

For more information about Bioject, visit: www.bioject.com.

Contacts

Bioject Medical Technologies Inc.
Ralph Makar, President and CEO, 503-692-8001 ext. 4137
or
Chris Farrell, Vice President of Finance, 503-692-8001 ext. 4132

Contacts

Bioject Medical Technologies Inc.
Ralph Makar, President and CEO, 503-692-8001 ext. 4137
or
Chris Farrell, Vice President of Finance, 503-692-8001 ext. 4132